drugset / Trial / NCT00960180
Study Evaluating Single Ascending Doses of MR1817
RandomizedSingle-groupTriple-blindTreatment
Summary
This is a first-in-human study of MR1817. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of MR1817 after administration of ascending single oral doses to healthy adult subjects.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MR1817 | Unknown | — | Oral |
Indications
No indication recorded.